ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,444.00
2.16%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36715
0.03%
Bitcoin
62,831.11
6.28%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) News

HRTX Heron Therapeautics Inc

2.60
0.05 (1.96%)
After Hours
Last Updated: 17:39:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Heron Therapeautics Inc HRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.05 1.96% 2.60 17:39:00
Open Price Low Price High Price Close Price Previous Close
2.67 2.57 2.74 2.61 2.55
more quote information »

Recent News

Date Time Source Heading
4/24/202407:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
4/11/202415:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
3/28/202415:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
3/13/202415:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
3/12/202415:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
3/12/202406:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
2/28/202407:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
2/14/202415:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202408:25APSPremarket Heats Up For Biotech Before Opening Bell
1/24/202407:01EDGAR2Form 8-K - Current report
1/23/202419:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
1/19/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202419:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/11/202415:07EDGAR2Form 8-K - Current report
1/07/202416:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
12/22/202315:30EDGAR2Form 8-K - Current report
12/21/202316:25EDGAR2Form 8-K - Current report
12/06/202315:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/21/202311:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202311:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202311:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202311:25APSBiotech Shares Up Sharply Following Quarterly Results
11/14/202315:10EDGAR2Form 8-K - Current report
11/14/202315:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
11/07/202315:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
10/17/202318:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/24/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/23/202315:08EDGAR2Form S-3 - Registration statement under Securities Act of..
8/14/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202315:11EDGAR2Form 8-K - Current report
8/14/202315:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..
8/07/202315:05PRNUSHeron Therapeutics to Report Second Quarter 2023 Financial..
8/01/202312:56EDGAR2Form D - Notice of Exempt Offering of Securities
7/25/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/25/202315:13EDGAR2Form SC 13D/A - General statement of acquisition of..
7/24/202308:12EDGAR2Form 8-K - Current report
7/24/202308:02PRNUSHeron Therapeutics Announces Cost Reduction Plan and..
7/24/202308:00PRNUSHeron Therapeutics Announces $30 Million Private Placement..
7/19/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/17/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
HRTX
Heron Therapeautics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved